Evidence map›Paper›PMID 31455920›Full record

ArticleNature biomedical engineering2019

Author Correction: Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy.

Ana M Moreno, Nathan Palmer, Fernando Alemán, Genghao Chen, Andrew Pla, Ning Jiang, Wei Leong Chew, Mansun Law, Prashant Mali

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. RevolutionizingFrontiers in genome editing · 2024
    Review
  3. CRISPR/Cas9 for hepatitis B virus infection treatment.Immunity, inflammation and disease · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ana M MorenoDepartment of Bioengineering, University of California San Diego, San Diego, CA, USA.
Nathan PalmerDivision of Biological Sciences, University of California San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-6347-9379
Fernando AlemánDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Genghao ChenDepartment of Bioengineering, University of California San Diego, San Diego, CA, USA.
Andrew PlaDepartment of Bioengineering, University of California San Diego, San Diego, CA, USA.
Ning JiangDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
Wei Leong ChewSynthetic Biology, Genome Institute of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4774-7959
Mansun LawDepartment of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Prashant MaliDepartment of Bioengineering, University of California San Diego, San Diego, CA, USA. pmali@ucsd.edu.ORCID http://orcid.org/0000-0002-3383-1287
University of California San Diego · USScripps Research Institute · USGenome Institute of Singapore · SGThe University of Texas at Austin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31455920
OpenAlexW2971154983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.